Press release
Investigation announced for Investors in shares of SCYNEXIS, Inc. (NASDAQ: SCYX) over possible Violations of Securities Laws
An investigation for investors in SCYNEXIS, Inc. (NASDAQ: SCYX) shares over potential securities laws violations by SCYNEXIS, Inc.
Investors who purchased shares of SCYNEXIS, Inc. (NASDAQ: SCYX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of SCYNEXIS, Inc. (NASDAQ: SCYX) concerning whether a series of statements by SCYNEXIS, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Jersey City, NJ based SCYNEXIS, Inc., a biotechnology company, develops products for the treatment of fungal infections in the United States. SCYNEXIS, Inc. reported that its annual Total Revenue declined from $13.16 million in 2021 to $5.09 million in 202, and that its Net Loss increased from $32.86 million in 2021 to $62.8 million in 2022.
Shares of SCYNEXIS, Inc. (NASDAQ: SCYX) declined from $3.87 per share on September 05, 2023, to as low as $1.625 per share on October 24, 2023.
Those who purchased shares of SCYNEXIS, Inc. (NASDAQ: SCYX) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of SCYNEXIS, Inc. (NASDAQ: SCYX) over possible Violations of Securities Laws here
News-ID: 3263619 • Views: …
More Releases from Shareholders Foundation
Lawsuit filed for Investors in Charge Enterprises, Inc. (formerly NASDAQ: CRGE) …
An investor, who purchased shares of Charge Enterprises, Inc. (formerly NASDAQ: CRGE), filed a lawsuit over alleged violations of Federal Securities Laws by the former CEO and CFO of Charge Enterprises, Inc in connection with certain allegedly false and misleading statements made between December 15, 2021 and February 28, 2024.
Investors who purchased shares of Charge Enterprises, Inc. (formerly NASDAQ: CRGE) between December 15, 2021 and February 28, 2024, and continue…
Deadline on June 10th coming up in Lawsuit for Investors in shares of Ocugen, In …
A deadline is coming up on June 10, 2024 in the lawsuit filed for certain investors of Ocugen, Inc. (NASDAQ: OCGN) over alleged securities laws violations by Ocugen, Inc.
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN ) have certain options and there are strict and short deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to…
Investigation announced for Investors in FMC Corporation (NYSE: FMC) over potent …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of FMC Corporation.
Investors who are current long term investors in FMC Corporation (NYSE: FMC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NYSE: FMC stocks follows a lawsuit filed against FMC Corporation over…
Investigation announced for Long-Term Investors who lost money with Advance Auto …
An investigation was announced for long-term investors in shares of Advance Auto Parts, Inc. (NYSE: AAP) concerning potential breaches of fiduciary duties by certain directors of Advance Auto Parts, Inc.
Investors who are current long term investors in Advance Auto Parts, Inc. (NYSE: AAP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long…
More Releases for SCYNEXIS
African Trypanosomiasis Treatment Market Expected to Develop by 2028 with COVID- …
This informative African Trypanosomiasis Treatment market report is highlighted at regional level to express the sales, growth and revenue of the particular regions. It reveals about the potential shortages and issues faced by many important industries. It focuses on macro-economic pointers along with principal market trends. It also displays competition in the market among the main profiles and the companies. Some of the key factors included in this African Trypanosomiasis…
Anti-fungal Drugs Market is expected to Witness the Highest Growth by 2026 Major …
Anti-fungal Drugs Market Forecast 2020-2026
The Global Anti-fungal Drugs Market research report provides and in-depth analysis on industry- and economy-wide database for business management that could potentially offer development and profitability for players in this market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The…
Evotec & Scynexis to lead the workshops for Superbugs & Superdrugs 2020
SMi Reports: Interactive workshop overview for SMi's 22nd Annual Superbugs & Superdrugs Conference, London in March 2020
SMi’s highly anticipated 22nd Annual Superbugs & Superdrugs Conference will commence on the 30th and 31st March 2020 and in London, UK.
For this year’s conference, industry leaders and key profiles from leading pharmaceutical organisations will be brought together to discuss the strategies in place that reduce AMR, evaluate the role pharmaceutical companies and funding…
Global Ileal Sodium/Bile Acid Cotransporter Market Size and Forecast 2025 : Albi …
Qyresearchreports include new market research report "Global Ileal Sodium/Bile Acid Cotransporter Market Insights, Forecast to 2025" to its huge collection of research reports.
The global Ileal Sodium/Bile Acid Cotransporter market is broadly shed light upon in the report while taking into consideration market dynamics, competition, segmentation, and other critical areas. With the help of modern primary and secondary research techniques, the authors of the report have done a brilliant job of…
Candidiasis Therapeutics - Clinical Trials & Results and Key Players Analysis SC …
The study analyzed that the candidiasis therapeutics pipeline comprises approximately 22 drug candidates in different stages of development.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/candidiasis-therapeutics-pipeline-analysis/report-sample
*Cochleate technology platform for Candidiasis drug development
Matinas Biopharma Holdings, Inc. is using Cochleate technology platform for the development of their drug candidates. The technology platform is a lipid-crystal nano-particle targeted drug delivery system, that offers a drug delivery solution with differentiating and disruptive features including oral availability, multi-organ…
Global Antifungal Market With Focus on Invasive Fungal Infections: Key Players - …
Researchmoz added Most up-to-date research on "Global Antifungal Market With Focus on Invasive Fungal Infections: Key Players - Pfizer, Inc., Merck Co., Inc. & Scynexis, Inc." to its huge collection of research reports.
The report titled Global Antifungal Market With Focus on Invasive Fungal Infections: 2016-2020 provides an in-depth analysis of the global antifungal market with detailed analysis of market size on the basis of value along with the comprehensive examination…
